Who
Jean-Manasse Theagene
Director
Company insider
Files Form 4 as: Director, MAIA Biotechnology.
In numbers
- Trades disclosed
- 18
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 31 Mar 2023
- Last trade
- 30 Sep 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 2 Oct 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —32,012 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,355 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,355 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,258 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,258 at $0.00 | filing |
| 31 Dec 2025filed 5 Jan 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,060 at $0.00 | filing |
| 31 Dec 2025filed 5 Jan 2026 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,060 at $0.00 | filing |
| 2 Oct 2025filed 6 Oct 2025 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,459 at $0.00 | filing |
| 30 Jun 2025filed 2 Jul 2025 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,380 at $0.00 | filing |
| 4 Apr 2025filed 8 Apr 2025 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,291 at $0.00 | filing |
| 31 Dec 2024filed 3 Jan 2025 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,225 at $0.00 | filing |
| 30 Sep 2024filed 2 Oct 2024 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,232 at $0.00 | filing |
| 30 Jun 2024filed 2 Jul 2024 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,728 at $0.00 | filing |
| 31 Mar 2024filed 2 Apr 2024 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,193 at $0.00 | filing |
| 31 Dec 2023filed 3 Jan 2024 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,418 at $0.00 | filing |
| 30 Sep 2023filed 3 Oct 2023 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,378 at $0.00 | filing |
| 30 Jun 2023filed 5 Jul 2023 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,910 at $0.00 | filing |
| 31 Mar 2023filed 4 Apr 2023 | MAIA MAIA Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —945 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.